The diagnostics company will participate in a fireside chat on Sept 10, focusing on its in vitro diagnostic technologies.
QuidelOrtho Corp will participate in the Baird 2025 Global Healthcare Conference, with management scheduled for a fireside chat on Wednesday, Sept 10, 2025, at 3:10 pm ET.
The San Diego-based company develops in vitro diagnostic technologies for point-of-care settings, clinical laboratories, and transfusion medicine applications. Laboratory professionals and investors can access the live webcast and replay through the “Events & Presentations” section of QuidelOrtho’s investor relations website.
The presentation comes as QuidelOrtho continues to expand its diagnostic portfolio across multiple testing platforms. The company specializes in immunoassay and molecular testing, clinical chemistry, and transfusion medicine solutions designed for various healthcare settings from home testing to hospital laboratories.
QuidelOrtho’s participation in the healthcare conference provides an opportunity for the company to discuss its strategic direction and market position with institutional investors and industry analysts. The Baird Global Healthcare Conference typically features presentations from leading healthcare companies across diagnostics, pharmaceuticals, and medical devices.
ID 44052476 © Rawpixelimages | Dreamstime.com
